Physician profile
Sandra Brafford
NPI 1386846517
$2,406.77
in general payments reported to CMS, 2019-2025
21 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $225 · 2021: $288 · 2022: $457 · 2023: $704 · 2024: $230 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $520.39 | 2021-2025 | Dalvance, Teflaro |
| Pfizer INC. | $429.70 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $286.30 | 2019-2025 | |
| Amgen INC. | $282.86 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $160.70 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $130.23 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.91 | 2021-2025 | Jardiance |
| Mylan Specialty L.P. | $101.67 | 2019-2023 | Yupelri |
| Merck Sharp & Dohme LLC | $81.57 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $48.00 | 2023 | Lokelma |
| Gilead Sciences, INC. | $34.35 | 2023 | Veklury |
| Exact Sciences Corporation | $34.14 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Cvrx, INC. | $31.73 | 2025 | Barostim Neo System |
| Allergan, INC. | $25.05 | 2020 | |
| Horizon Therapeutics Plc | $23.73 | 2023 | Uplizna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $21.60 | 2023 | Fetroja |
| Vifor Pharma, INC. | $20.65 | 2019 | |
| Global Blood Therapeutics, INC. | $19.97 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.92 | 2025 | Lifevest |
| Smith+Nephew, INC. | $17.47 | 2023 | Collagenase Santyl |
| Portola Pharmaceuticals, LLC | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Brafford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.